Patients unable to swallow meals on their own can receive nutrition support through enteral feeding devices. Even patients who need nutritional supplements can utilize them. Patients unable to maintain adequate nourishment owing to medical conditions are prescribed it. Patients with chronic illnesses, such as cancer, malnutrition, gastrointestinal disorders, etc., are fed by enteral feeding apparatuses. The gastrointestinal tract is used to transport food via the enteral feeding apparatus. In order to use the perpetual feeding system, the patient must have an accessible and functional gastrointestinal tract. These feeding apparatuses are generally utilized in intensive care units, operating rooms, and critical care units. Patients with a history of chronic disease can also employ home-based perpetual feeding equipment.
The market for enteral feeding devices will grow rapidly, with a CAGR of 6.38%, from $3.48 billion in 2021 to $6.088 billion by 2030.
Market Dynamics
Drivers
One of the major aspects propelling the market’s expansion is the rising incidence of chronic diseases like diabetes, cancer, and gastrointestinal disorders. Additionally, the market is growing due to the growing elderly population, which is more vulnerable to such medical conditions. The patient’s ability to swallow is affected by illnesses and neurological diseases such as multiple sclerosis, stroke, and dementia, which can lead to malnutrition. The market is rising due to numerous technological developments, such as the creation of low-profile gastrostomy buttons that are appropriate for pediatric and adult patients.
Restraints
When using enteral feeding systems, patients might experience specific difficulties. These side effects resemble parenteral feeding issues in certain ways. The most frequent side effects are diarrhea, abdominal infections, dehydration, and constipation. Enteral feeding equipment needs to be efficiently and correctly maintained to prevent difficulties. As a result, it prevents the market for enteral feeding systems from expanding.
Opportunity
Due to its high-quality and various healthcare markets, expanding prevalence of R&D initiatives for creating innovative feeding technologies, the ongoing rise in chronic disorders and infectious diseases, etc., the APAC area will offer significant growth prospects in the future. Additionally, more affordable feeding device production would encourage future prudent enteral feeding device investment in this region from the major market participants.
Market Segmentation
Product Type Insights
The enteral feeding pump segment accounted for more than 40.0% of total revenue in 2021. In order to improve nutrient absorption and prevent malnutrition, which is common as these conditions reduce oral nutrition intake, enteral-based feeding or nutrition is frequently used for the pediatric and adult population diagnosed with chronic diseases, which further drives the segment. This market’s expansion will be driven due to the increasing use of these safe and nutrient-dense devices in hospitals and at-home care settings.
Application Insights
Gastrointestinal, hypermetabolism, neurology, cancer, diabetes, and others comprise the application section. In 2021, the gastrointestinal sector had the biggest market, with a 32.11% revenue share. Patients with gastrointestinal conditions typically cannot absorb nutrients for proper bodily function.
End-User Insights
Hospitals generated 47.54% of the market’s revenue in 2021. As a result of many patients being hospitalized, hospitals are using more enteral feeding systems. Enteral feeding devices must be used during general and specialty operations because most patients cannot absorb nutrients.
Regional Insights
In 2021, North America had the highest revenue share with almost 35.0%. Due to the prevalence of a sizable senior population suffering from chronic diseases, the regional market has grown. For instance, according to data from the Centers for Disease Control and Prevention, 60% of older people have at least two chronic conditions, and 85% cope with at least one chronic disease.
Asia Pacific area will expand at a rapid 5.5% CAGR. Adopting cutting-edge medical technology and expanding healthcare infrastructure will drive market expansion. A few other important aspects that influence the market are the rising proportion of hospital admissions, premature births, malnourished population, and the aging population.
Key Players
- Boston Scientific Corporation
- Danone S.A.
- Becton, Dickinson, and Company
- CONMED Corporation
- Cardinal Health Inc.
- Fresenius Kabi
- Vygon Group
- Moog Inc.
- Cook Medical
- Nestlé S.A.
- Baxter International Inc.
- Amsino International Inc.
- Braun Melsungen AG
- Avanos Medical Inc
- Omex Medical Technology
- Applied Medical Technology
- Kentec Medical Inc.
- Medline Industries, Inc.
- Vesco Medical LLC
- Danumed Medizintechnik
- Fuji Systems Corporation
- Medela Inc.
- Dynarex Corporation
- Alcor Scientific
The market for enteral feeding devices will grow rapidly, with a CAGR of 6.38%, from $3.48 billion in 2021 to $6.088 billion by 2030. The main drivers of this market’s expansion are the aging population and its subsequent rise in the prevalence of chronic diseases, the switch from parenteral to enteral nutrition, technological improvements in enteral feeding systems, and rising demand for enteral feeding in home care settings.
Related Reports:
Sports Medicine Market Report – The global sports medicine market will witness a robust CAGR of 6.2%, valued at $6.90 billion in 2021, expected to appreciate and reach $11.86 billion by 2030, confirms Strategic Market Research. North America maintained a leading market share of 39 % in 2021.
